• Immunohistochemistry with Anti-SEPT5 Antibody (STJ502910) at 1:50 dilution in Buffer. DAB (brown) staining and Haematoxylin QS (blue) counterstain. 40X magnification. FFPE section.

Anti-SEPT5 antibody (300-350) (STJ502910)

SKU:
STJ502910-100

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: ELISA/IHC/IP/WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-SEPT5 (300-350) is suitable for use in ELISA, Immunohistochemistry, Immunoprecipitation and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Purification: Affinity Purified
Concentration: 0.64-0.72 µg/µl
Dilution Range: WB: 1:500
DB: 1:10, 000
ELISA: 1:10, 000
IP: 1:200
IHC: 1:50-1:150
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Gene Symbol: SEPTIN5
Gene ID: 5413
Uniprot ID: SEPT5_HUMAN
Immunogen Region: 300-350
Immunogen: Synthetic peptide taken within amino acid region 300-350 on SEPT5 protein.
Tissue Specificity Expressed at high levels in the CNS, as well as in heart and platelets (at protein level).
Post Translational Modifications Phosphorylated by DYRK1A. In platelets, phosphorylated in response to thrombin, phorbol-12-myristate-13-acetate and collagen.
Function Filament-forming cytoskeletal GTPase. May play a role in cytokinesis (Potential). May play a role in platelet secretion.
Protein Name Septin-5
Cell Division Control-Related Protein 1
Cdcrel-1
Peanut-Like Protein 1
Cellular Localisation Cytoplasm
Cytoskeleton
In Platelets
Found In Areas Surrounding Alpha-Granules
Alternative Antibody Names Anti-Septin-5 antibody
Anti-Cell Division Control-Related Protein 1 antibody
Anti-Cdcrel-1 antibody
Anti-Peanut-Like Protein 1 antibody
Anti-SEPTIN5 antibody
Anti-PNUTL1 antibody
Anti-SEPT5 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance